FACULTY DISCLOSURES
Larry Culpepper, MD, MPH, is a consultant and is on the speakers' bureau for AstraZeneca Pharmaceuticals, Forest Laboratories, Pfizer Inc, and Wyeth Pharmaceuticals.
Mary Moller, DNP, ARNP, BC, CPRP, is on the speakers' bureau for Wyeth Pharmaceuticals.
Catherine Judd, PA, is on the speakers' bureau for Bristol-Myers Squibb Company and is on the advisory board for AstraZeneca Pharmaceuticals, and Eli Lilly and Company.
Charles Nemeroff, MD, PhD, received grant/research support from AstraZeneca Pharmaceuticals, Bristol-Myers Squibb Company, Forest Laboratories, Janssen Pharmaceutica, Pfizer Inc, Wyeth Pharmaceuticals, AFSP, NARSAD, and NIMH; is a consultant for Abbott Laboratories, Acadia Pharmaceuticals, Bristol-Myers Squibb Company, Corcept Therapeutics, Cypress Biosciences, Cyberonics, Eli Lilly & Company, Forest Laboratories, GlaxoSmithKline, Janssen Pharmaceutica; Otsuka America Pharmaceutical Inc; Pfizer Inc; Quintiles, UCB Pharma, and Wyeth Pharmaceuticals; is on the speaker's bureau for Abbott Laboratories, GlaxoSmithKilne, Jannsen Pharmaceutica, and Pfizer Inc; and has stock/shareholder with Acadia Pharmaceuticals, Corcept Therapeutics, Cypress Biosciences, and NovaDel Pharma, Inc.; and is on the Board of Directors of Novadel Pharma.
Mark Rapaport, MD, received grant/research support from Abbott Laboratories, AstraZeneca Pharmaceuticals, Coricept Therapeutics, Cyberonics, Inc, Forest Laboratories, GlaxoSmithKiline, Janssen Pharmaceutica, Novartis Pharmaceuticals, Pharmacia-Upjohn, Pfizer Inc, Sanofi-Synthelabo, Solvay, Stanley Foundation,UCB Pharma, Inc, Wyeth Pharmaceuticals, NIMH, and NCCAM; is a consultant/lecturer for Cyberonics, Inc, Eli Lilly and Company, Forest Laboratories, GlaxoSmithKline, Janssen Pharmaceutica, Neurocrine Biosciences, Novartis Pharmaceuticals, Pfizer Inc, Roche Laboratories, Sanofi-Synthelabo, Solvay, Sumitomo, Wyeth Pharmaceuticals, NIMH, and NIDA; is on the speakers' bureau for Cyberonics, Inc, Eli Lilly and Company, Forest Laboratories, GlaxoSmithKline, Janssen Pharmaceutica, Novartis Pharmaceuticals, and Pfizer inc; and has stock/shareholder with Forest Laboratories.
NOTICE: Boston University School of Medicine advises the audience that one or more presentations in this continuing medical education activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices.
Dr. Rapaport intends to reference unlabeled/unapproved uses of a commercial product and will disclose this to the audience.